DexCom
DXCM
DXCM
793 hedge funds and large institutions have $51B invested in DexCom in 2021 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 280 increasing their positions, 275 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
10% more funds holding
Funds holding: 724 → 793 (+69)
2% more repeat investments, than reductions
Existing positions increased: 280 | Existing positions reduced: 275
5.17% less ownership
Funds ownership: 392.51% → 387.34% (-5.2%)
Holders
793
Holding in Top 10
15
Calls
$1.09B
Puts
$925M
Top Buyers
| 1 | +$199M | |
| 2 | +$145M | |
| 3 | +$134M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$128M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$125M |
Top Sellers
| 1 | -$456M | |
| 2 | -$381M | |
| 3 | -$215M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$129M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$128M |